Disease Specific Biomarkers in Transthyretin amyloidosis as new tools for diagnosis and response to therapy prediction: Where are we standing?

Joel Buxbaum (The Scripps Research Institute, La Jolla, CA, USA)
12h – Salle de réunion du Département de Pathologie de l’hôpital Henri Mondor (RDC-haut)
Séminaire du Service de Neurologie de l’hôpital Henri Mondor.
Contacts : Marie-Violaine Plante-Bordeneuve et Farida Gorram